Global Health Industry Headlines: IPOs, Drug Breakthroughs, and Policy Shifts
Published on: March 27, 2026, 2:29 a.m. | Source: Devdiscourse
Recent health news highlights include Grifols' U.S. biopharma business planning an IPO, Kodiak Sciences’ share surge after a successful study, and a bipartisan U.S. Senate deal to cap insulin prices at $35. Several companies face FDA challenges, fresh drug approvals are noted, and global policies impacting health are addressed.
